The quality of evidence for medical interventions does not improve or worsen: a metaepidemiological study of Cochrane reviews.


Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
10 2020
Historique:
received: 26 06 2020
revised: 05 08 2020
accepted: 05 08 2020
pubmed: 6 9 2020
medline: 5 3 2021
entrez: 5 9 2020
Statut: ppublish

Résumé

The objective of the study was to determine the change in quality of evidence in updates of Cochrane reviews that were initially published between January 1, 2013 and June 30, 2014. We used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system to document evidence quality. We searched the Cochrane Database of Systematic Reviews on March 20, 2020 to identify which of the reviews from the initial (2013/14) sample had been updated. Using the same methods to determine the quality of evidence in the previous analysis, we assessed the quality of evidence for the first-listed primary outcomes in the updated reviews. Of the 608 reviews in the original sample, 154 had been updated with and 151 contained available data for both original and updated systematic reviews (24.8%). The updated reviews included: 15 (9.9%) with high-quality evidence, 56 (37.1%) with moderate-quality evidence, 47 (31.1%) with low-quality evidence, and 33 (21.9%) with very low-quality evidence. No change in the GRADE quality of evidence was found for most (103, 68.2%) of the updated reviews. The quality of evidence rating was downgraded in 28 reviews (58.3%) and upgraded in 20 (41.7%), although only six reviews were promoted to high quality. Updated systematic reviews continued to suggest that only a minority of outcomes for health care interventions are supported by high-quality evidence. The quality of the evidence did not consistently improve or worsen in updated reviews.

Identifiants

pubmed: 32890636
pii: S0895-4356(20)30777-0
doi: 10.1016/j.jclinepi.2020.08.005
pii:
doi:

Types de publication

Comparative Study Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

154-159

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Jeremy Howick (J)

Faculty of Philosophy, University of Oxford, Oxford OX2 6GG, UK. Electronic address: jeremy.howick@philosophy.ox.ac.uk.

Despina Koletsi (D)

Clinic of Orthodontics and Pediatric Dentistry, Center of Dental Medicine, University of Zurich, Zurich, Switzerland.

Nikolaos Pandis (N)

Department of Orthodontics and Dentofacial Orthopedics, School of Dental Medicine, Medical Faculty, University of Bern, Bern, Switzerland.

Padhraig S Fleming (PS)

Institute of Dentistry, Queen Mary, University of London, London, United Kingdom.

Martin Loef (M)

CHS-Institute, Berlin, Germany.

Harald Walach (H)

CHS-Institute, Berlin, Germany; Department of Pediatric Gastroenterlogy, Poznan University of the Medical Sciences, Poznan, Poland.

Stefan Schmidt (S)

Department of Psychosomatic Medicine and Psychotherapy, Medical Center, University of Freiburg, Freiburg, Germany.

John P A Ioannidis (JPA)

Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics, Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH